Jubilant Ingrevia Acquires 100% Stake in Remidex Pharma
Jubilant Ingrevia Limited announced the completion of its acquisition of a 100% equity stake in Remidex Pharma Private Limited on March 30, 2026, at 6:05 pm (IST). The acquisition follows a Share Purchase Agreement entered into with Remidex. Key terms of the transaction were previously disclosed on March 13, 2026.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.